Track topics on Twitter Track topics that are important to you
140 Geary Street Tenth floor
United States of America
Phone: 415 228 3380
Fax: 415 228 3390
Oncology start-up VelosBio Inc. raised $58mm through its Series A round. Arix Bioscience and Sofinnova Ventures co-led and were joined by Pappas Ventures, Chiesi Ventures, and returning backers Takeda...
NextCure Inc. (immunotherapies) raised $93mm through its Series B round. Hillhouse Capital and Quan Capital led, and were joined by Bay City Capital, Surveyor Capital (Citadel), Ping An Ventures, Taih...
Akouos, a Boston, MA-based precision genetic medicine company developing gene therapies that restore and preserve hearing has raised $50 million in Series A funding co-led by 5AM Ventures and New Ent...
Aspect Ventures led the $10 million Series A round. BBG Ventures, LaunchCapital, iNovia, RiverPark Ventures, Ulu Ventures, Day One Ventures and Portfolia participated.
Arix Bioscience co-leads round with Sofinnova Ventures, investing $11 million and taking an 11.2 percent ownership stake in the San Diego-based firm.
Sofinnova invest early in projects with disruptive technologies that have the potential to become strong sustainable companies with the potential to return in excess of 10x their investment. Antoine P...
Galera Therapeutics Inc. (developing cancer treatments that target oxygen metabolic pathways) raised $70.2mm through its Series C round. New investor Clarus led (and takes a board seat) and was joined...
Gene therapy developer XyloCor Therapeutics Inc. raised $17mm in its Series A financing led by Sofinnova Ventures and LSP, which each add a board member.
B4 Brands: Avant EX Instant Hand Sanitizer
B4 Brands: Avant Foaming Hand Sanitizer - Fragrance Free
B4 Brands: Avant Original Instant Hand Sanitizer
B4 Brands: Aterra Antibacterial Hand Soap
B4 Brands: Avant Original - Fragrance Free Instant Hand Sanitizer
Deforestation is a significant source of man-made carbon in the atmosphere, contributing to the greenhouse gas (GHG) effect. Although carbon releases are associated to the ecosystem functions of clima...
Overconfidence has been reported to be a common bias among entrepreneurs and might be one cause of the high failure rates observed for new ventures. In this study, we investigate the overconfidence bi...
It is evidenced that 20% of all tumors in humans are caused by oncoviruses including Human Papilloma Viruses (HPV), Epstein-Barr Virus (EBV), Kaposi Sarcoma Virus (KSHV), Human Polyomaviruses (HPyV), ...
Product reviews are the individual's opinions, judgement or belief about a certain product or service provided by certain companies. Such reviews serve as guides for these companies to plan and monito...
Light microscopy, which is based on century-old technology, remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalaria...
Microscopy remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalarials or in the context of regulatory clinical trial...
Sofinnova Ventures we are company builders who work with our entrepreneurs as a team. Our firm, based in San Francisco and founded in 1974, invests venture capital in early-stage Life Science and Info...
1972 Sofinnova is the first venture capital company created in France.Sofinnova Partners is an independent venture capital company based in Paris. We have special relations with Sofinnova Ventures, o...
NuCanaÂ® is a rapidly growing, clinical stage biopharmaceutical company with a broad development portfolio of novel anti-cancer medicines. The Companyâs proprietary ProTide...
Marinus is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders. Marinus ...
Catalyst Biosciences is developing the next generation of biopharmaceuticals by harnessing the catalytic power of engineered proteases that target proteins underlying diseases. Catalyst's discovery p...
We have published hundreds of Sofinnova Ventures news stories on BioPortfolio along with dozens of Sofinnova Ventures Clinical Trials and PubMed Articles about Sofinnova Ventures for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sofinnova Ventures Companies in our database. You can also find out about relevant Sofinnova Ventures Drugs and Medications on this site too.